Delivery Order SPE2DB20D7059-SPE2DB23FPVM6
Award Date
1/4/23
Potential Completion Date
1/5/23
Potential Value
$3.3K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Cencora, Inc.
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of Dupixent 300 mg/2 ml syringes. The $15,826.08 award has an ultimate completion date of April 3, 2024. Amerisourcebergen Drug Corp, as the prime contractor, holds an indefinite delivery contract (IDC) with DLA valued at up to $999,999,999.00, which serves as the primary vehicle for the company to provide pharmaceutical...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract valued at $11,616.24 to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to provide 4,564,145,782 units of the pharmaceutical product Dupixent 300 mg/2 ml syringe 2 ml. This delivery order is part of a larger indefinite delivery contract (IDC) awarded solely to AmerisourceBergen Drug Corp, with a potential value of $999,999,999.00 and a performance period through December 31,...
The Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order valued at $14,937.00 to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, for the procurement of 4,564,110,516 units of the pharmaceutical product Dupixent 300 mg/2 ml Syringe (2 ml). The delivery order is part of a larger indefinite delivery contract (IDC) awarded solely to AmerisourceBergen Drug Corp, valued at up to $999,999,999.00 and with a performance period through December 31, 2025....
The U.S. Defense Logistics Agency (DLA) awarded a delivery order contract valued at $24,419.18 to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Dupixent 300 mg/2 ml syringes and has a completion date of February 3, 2025. This delivery order is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, valued at $999,999,999 and running through...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract worth $9,914.10 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical distributor. The contract is for the supply of Dupixent 300 mg/2 ml syringes to support military treatment programs and facilities. This delivery order is part of a larger indefinite delivery contract (IDC) awarded solely to Amerisourcebergen Drug Corp, with a potential value of...
The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a $1,652.35 firm fixed price delivery order contract to AmerisourceBergen Drug Corp's Corporate Office division. The order is for Dupixent 200 mg/1.14 ml syringes, and has an ultimate completion date of August 2, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical to provide a comprehensive range of...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract worth $12,507.37 to AmerisourceBergen Drug Corp, a subsidiary of the global pharmaceutical distribution company AmerisourceBergen Corporation. This order is for the supply of the specialty pharmaceutical product Dupixent 300 mg/2 ml pen, with an ultimate completion date of March 19, 2024. AmerisourceBergen Drug Corp holds an indefinite delivery contract (IDC) with DLA, valued at up to $999,999,999.00...
The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract worth $9,914.10 to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, for the supply of Dupixent 300 mg/2 ml pens. This delivery order is part of a larger indefinite delivery contract (IDC) valued at up to $999,999,999.00 awarded by DLA to AmerisourceBergen Drug Corp, which serves as the primary vehicle for the company to provide pharmaceutical products and medical supplies to DLA Troop...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of the parent company AmerisourceBergen Corporation. The $14,117.12 contract is for the supply of Dupixent 300 mg/2 ml pen medication. This award is part of a larger indefinite delivery contract (IDC) between DLA Troop Support Medical and AmerisourceBergen Drug Corp, valued at up to $999,999,999.00 through December 31, 2025. The IDC serves as the primary vehicle...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to provide Dupixent 300 mg/2 ml syringes. The delivery order, valued at $9,914.10, is a firm fixed price contract with a period of performance through March 29, 2024. AmerisourceBergen Drug Corp is the prime contractor and no set-aside designation was used. In addition to this delivery order, AmerisourceBergen Drug Corp holds an indefinite delivery...